Last reviewed · How we verify
Alpha-Lipoic Acid(α-LA) — Competitive Intelligence Brief
marketed
Antioxidant/Mitochondrial cofactor
Metabolic/Endocrine
Small molecule
Live · refreshed every 30 min
Target snapshot
Alpha-Lipoic Acid(α-LA) (Alpha-Lipoic Acid(α-LA)) — Shanghai Zhongshan Hospital. Alpha-lipoic acid acts as a mitochondrial cofactor and antioxidant that reduces oxidative stress and improves cellular energy metabolism.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Alpha-Lipoic Acid(α-LA) TARGET | Alpha-Lipoic Acid(α-LA) | Shanghai Zhongshan Hospital | marketed | Antioxidant/Mitochondrial cofactor |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Antioxidant/Mitochondrial cofactor class)
- Shanghai Zhongshan Hospital · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Alpha-Lipoic Acid(α-LA) CI watch — RSS
- Alpha-Lipoic Acid(α-LA) CI watch — Atom
- Alpha-Lipoic Acid(α-LA) CI watch — JSON
- Alpha-Lipoic Acid(α-LA) alone — RSS
- Whole Antioxidant/Mitochondrial cofactor class — RSS
Cite this brief
Drug Landscape (2026). Alpha-Lipoic Acid(α-LA) — Competitive Intelligence Brief. https://druglandscape.com/ci/alpha-lipoic-acid-la. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing